Since the mouse offers an easily manipulated experimental animal model for the study of the immunopathogenesis of pneumonia caused by the opportunist Pneumocystis carinii, we cloned and characterized cDNAs encoding an abundant, immunogenic surface antigen termed glycoprotein A (gpA) from mouse P. carinii. A cDNA library was constructed in bacteriophage Agtll from P. carinii -infected mouse lung poly(A+) RNA. Using a nucleic acid probe derived from a conserved region of the mouse P. carinii gpA structural gene, cDNAs encoding gpA were identified. A composite full-length gpA coding sequence was assembled from two overlapping cDNA clones. A DNA element homologous to the rat P. carinii upstream conserved sequence (UCS) was identified at the 5' end of several of the mouse P. carinii gpA cDNA clones, just upstream of the sequences encoding gpA structural gene isoforms. Using primer extension analysis, two neighboring putative transcriptional start sites were located on UCS-gpA mRNAs approximately 25 and 30 nt, respectively, upstream of the most 5' gpA cDNA clone isolated, suggesting a 5' UCS of 489 or 494 nucleotides in mouse P. carinii gpA. A comparative alignment of the composite mouse P. carinii gpA deduced amino acid sequence with gpA homologs from rat, human and ferret P. carinii demonstrated 156 identical residues, including 46 cysteines, further supporting the hypothesis for conserved secondary structure, as well as function, for gpA from all P. carinii.
1. Introduction lated from P. carinii -exposed rats and sensitized to gpA in vitro reduce the severity of disease upon adoptive In pulmonary infection caused by the opportunistic transfer to rats exhibiting PCP. 12 Furthermore, gpA conpathogen Pneumocystis carinii, prominent humoral and tains mannose, which is a specific ligand of the mannose cell-mediated host responses are mounted against the binding protein, and thereby serves as a potential tarabundant, immunodominant, polymorphic P. carinii sur-g e t for uptake of P. carinii by alveolar macrophages, 13 ' 14 face antigen, glycoprotein A 1 " 4 (gpA; also referred to as classically the first line of defense against pulmonary major surface glycoprotein or MSG 5 " 7 ). Rats display a pathogens at the level of the alveoli. From a funcprominent antibody response against this antigen after tional perspective, gpA has been implicated in the atrecovery from P. carinii pneumonia (PCP), as well as af-tachment of P. carinii to alveolar epithelial cells and ter natural exposure to P. carinii in the environment. 8 alveolar macrophages via components of the host extraPassive immunization with a monoclonal antibody tar-cellular matrix such as fibronectin, 15 " 17 and in binding to geting gpA results in partial protection against PCP components of host surfactant, 18 " 20 possibly accounting through a significant reduction in organism burden in j n p a r t for the hypoxia seen in PCP. the host. 9 ' 10 A specific T-lymphocyte response to gpA Given the above observations, gpA is a rational tarhas been observed in animals recovering from PCP and in g e t for more detailed evaluation at the molecular level, animals immunized with either P. carinii -infected crude Because the mouse is highly amenable to genetic and lung homogenates or purified native gpA. 11 T cells iso-immunologic manipulations, and because of the lack Communicated by Yoshikazu Nakamura o f cross-species transmission of P. carinii, the molec-* To whom correspondence should be addressed. Tel. +1-ular cloning and characterization of the cDNA encod-716-275-0678, Fax. +1-716-473-9573, E-mail: haid@uhura.cc. i n g p. carinii gpA from a SCID mouse model of PCP rochester.edu w a s p e r f o r m e d T h e r e s u lting full-length gpA cDNA de-[Vol. 5, scribed in this report will allow us to define further the role of gpA in the biology of host-P. carinii interactions.
Materials and Methods

2.1.
Construction and screening of a mouse P. carinii cDNA clone bank. Lungs from dexamethasone-immunosuppressed C.B-17 SCID mice with a heavy P. carinii infective burden were a generous gift from Dr. Allen G. Harmsen of the Trudeau Institute (Saranac Lake, NY). Total and poly (A+)-selected RNAs were isolated, and first and second strand cDNA synthesis was carried out as previously described. 2 To protect against restriction at internal sites during EcoRI linker digestion, the double-stranded cDNA was methylated using EcoRI methylase (Promega, Madison, WI). The completion of construction of the cDNA clone bank in Agtll was performed using EcoRI-treated Agtll DNA arms and bacteriophage A packaging extracts (Gigapack II Gold) from Stratagene (San Diego, CA). 2 
Nucleic acid screening of a mouse-derived P. carinii
gpA cDNA library. Approximately ~ 5 x 10 6 plaque-forming units (pfu) of the mouse-derived P. carinii gpA cDNA library was screened by nucleic acid hybridization 2 using a radiolabelled mouse P. carinii gpA specific DNA probe, derived from a genomic clone previously identified, 4 and autoradiography. The probe was prepared by polymerase chain reaction (PCR) amplification using primer pairs specific for a conserved cysteine-rich region (Cys-sense: 5'-AGAG(T/C)AGC(G/C)TG(C/T)TA(T/C)AA(A/G)-AA(A/G)GG-3' and Cys-antisense: 5'-ACA-(C/T)T-(T/G)CTCCTTCAA(C/T)TCAACACA-3')- 4 These and all other oligodeoxyribonucleotide primers used were synthesized by the University of Rochester Core Nucleic Acid Laboratory.
Production of polyclonal rabbit anti-mouse
P. carinii gpA immune serum. Polyclonal antiserum against mouse P. carinii gpA was produced by immunization of one NZW rabbit (Hazelton Research Products, Denver, PA) with mouse P. carinii gpA-bearing nitrocellulose particles. 21 ' 22 Rabbit immune serum specificity for mouse P. carinii gpA was confirmed by Western blotting and immunofluorescence assays. 21 2.4-Antibody screening of mouse P. carinii gpA cDNA sublibrary to identify expressed clones. Bacteriophage found to yield a positive signal by nucleic acid screening were aliquoted into pools for further analysis. Phage were plated at moderate density, and induction of /3-galactosidase fusion proteins was performed. 2 Rabbit immune serum was adsorbed twice against lung homogenates from uninfected BALB/c mice and three times against Escherichia coli Y1090r-m+ to decrease nonspecific binding, and was used at a dilution of 1 : 2000 as the primary antibody. To detect bound antibody, 125 I-labeled Protein A (Amersham, Arlington Heights, IL) was used. Filters were processed as before, 2 air dried, and exposed to film. Phage clones positive by nucleic acid probe hybridization that were positive in this antibody screen were isolated and stored for subsequent analysis.
Subcloning of mouse P. carinii gpA cDNAs, DNA
sequencing and sequence data analysis. To determine the size of the cDNA insert in each of the 211 nucleic acid probe-and antibody-positive Agtll clones, a PCR-based strategy was devised using two PCR primers that were specific for the conserved cysteine-rich region of gpA targeted in the initial screening of the library ( Fig. 1 ; sense primer: bases 1726-1756; antisense primer: complementary sequences to bases 1875-2000), as well as forward and reverse primers specific for the region flanking the EcoRI cloning site in Agtll. Agarose gel electrophoresis of the PCR products was used to gauge the sizes of cDNA inserts in the various phage clone samples, and thus to classify individual cDNA clones by total insert size and their relative position in the context of the full-length gpA cDNA. The six largest Agtll clones were plaque purified: clones 1, 2, 3, 6, 7, and 8, with approximate cDNA insert sizes of 2.7, 2.0, 2.6, 3.1, 2.8, and 2.5 kb, respectively.
Following plaque purification, DNA was isolated from these Agtll clones, 23 inserts were released by EcoRI digestion, and the cDNAs were subcloned into the histidine tag expression vector, pTrcHisB (Invitrogen Corp., San Diego, CA), in which the reading frame of Agtll was maintained. DNA sequencing of portions of each of the mouse P. carinii gpA cDNA clones listed above was performed using fluorescent dye-labeled dideoxynucleotides (ABI PRISM Kit, Perkin Elmer, Norwalk, CT) by the University of Rochester Core Nucleic Acid Laboratory. In addition, cDNA clone 6 (3.1 kb) was sequenced in its entirety by Lark Technologies, Inc. (Houston, TX). Analysis of the sequence data was carried out using the Genetics Computer Group (GCG, University of Wisconsin), 24 and Mac Vector (IBI-A Kodak Company) 25 software packages.
RNA primer extension assays.
To determine the start site of gpA transcription relative to the 5' end of the cDNA clones isolated, RNA primer extension was performed. 4 Labeled primers were mixed with 10-30 /xg total RNA. After denaturation and hybridization, samples were allowed to cool slowly to 42 °C, reverse transcriptase (Superscript II, Life Technologies, Rockville, MD) and primer extension buffer were added to final concentrations of 20 mM Tris-HCl, GGA GGA TCA ACA CCA AGT GGA ACG ACA AAC ACG AGT AAT GTT ATA CTT GTT CGG AGA ACA TTT GTA AGT GGA GAA GTA TCA 3240
GAA CCA GAA AAG AAG GCA TTT GTT GCA ACG GCG AGA GCA TTG GAA TTG TAT TTA GAA TTG AAA GAG AAA TGT AAA GGT TTG 3 3 2 1
AAA GGA GAC TGC GAG TTT AGA AAG GAT TGC CCG AAG TGT GAA ACG GTC TGT AAA GAA ATA GAi , TTG TGT GAA GGA ATA 3402 ACG ACG ACA ACA ACA ACA ACG ACG ACG ACG ACA ACG ACA ACG ACG GCA ACG ACG ACA GAA TCG  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  A  T  T  T  E Figs. 1 and 2 ).
Results and Discussion
Identification of cDNAs encoding mouse P. carinii
gpA. A cDNA library was constructed in bacteriophage Agtll using mouse P. carinii -infected lung poly(A+) RNA. The expression library contained 1.3 x 10 7 total recombinant phage with a 97% frequency of recombinants. Over 3200 gpA-positive plaques were isolated following screening of the library by nucleic acid hybridization with the mouse P. carinii gpA-specific DNA probe derived from the conserved cysteine region found initially in rat and ferret P. carinii gpAs. 4 Among the clones selected by nucleic acid hybridization, 211 clones were subsequently identified by expression screening with polyclonal rabbit anti-mouse P. carinii gpA immune serum and 125 Ilabeled Protein A.
Six of the largest expressing cDNAs were subcloned into pTrcHis for nucleotide sequencing of each end of the clones. Four of the six clones shared identical sequences over approximately the first 300 nucleotides (nt) of their 5' ends, which, upon further analysis, was determined to be the equivalent of the UCS 26 "" 28 for mouse gpA (described below). Based on homology to rat P. carinii MSG sequences, 5 " 7 ' 29 the remaining two clones were located at the 3' end of gpA. The two 3' end clones also shared approximately 300 nt of identical sequence. From the preliminary sequence analysis, it was evident that two of the clones, one from the 5' end of the cDNA and the other from the 3' end, overlapped extensively and encompassed the extreme ends of the cDNA. Clone 3 was 2.6 kb and, of the clones isolated, extended the furthest toward the 5' end of the cDNA. Clone 6 was 3.1 kb and extended to the 3' end of the cDNA. Clones 3 and 6 overlapped by approximately 1500 base pairs (bp). The first 1919 bp of the nucleotide sequence was determined for the 2.6 kb, 5' cDNA (clone 3); and, the entire nucleotide sequence of the 3.1 kb, 3' cDNA (clone 6), was determined. Over the first 992 bp of overlap between clones 3 and 6, the nucleotide sequences were 94% identical (data not shown). The sequences of the two clones were assembled to form the composite mouse P. carinii gpA sequence shown in stop codon. Unmodified, the predicted molecular weight of this protein was 141,869 Da, which is consistent with prior SDS-PAGE and immunoblotting data. 21 The apparent molecular weight of native gpA ranges from approximately 97 to 140 kDa, depending on the host species from which the organism is isolated, with mannose being the predominant carbohydrate residue. 21 At approximately 140 kDa, mouse P. carinii gpA represents the largest of the reported gpA homologs. Despite having the largest protein core, mouse P. carinii gpA has the fewest potential N-linked glycosylation sites (5), compared to 6 in the rat, 6 10 in the human, 30 and 13 in the ferret 3 P. carinii gpA homolog. The implications of this disparity remain uncertain, but it may suggest that all the potential N-linked glycosylation sites in gpA are not utilized in the human-and ferret-derived homologs. It is unknown whether mouse P. carinii gpA contains 0-linked carbohydrate, but the conserved threonine-serine domain is a candidate site for this modification (Fig. 1 , amino acids 1144-1236; see also Fig. 4B ). While the role of gpA carbohydrate in the attachment of P. carinii to either extracellular matrix 15 "" 17 or surfactant 18 " 20 components has not been defined, the glycosylation pattern of gpA and its corresponding carbohydrate structure has immunological relevance in light of the binding interaction of native gpA with the macrophage mannose receptor. 14 
Characterization of the upstream conserved
sequence of mouse-derived P. carinii associated with gpA cDNAs. Four of the six largest cDNA clones identified by immunoscreening had regions of identity at the 5' end. Comparison of these sequences to the rat P. carinii upstream conserved sequence (UCS) demonstrated 60% homology overall (Fig. 2) . A 40-bp region of identity near the 5' end (mouse P. carinii UCS bp 52-91), and a 15-bp region of identity at the 3' end of the mouse and rat P. carinii UCS sequences were notable. The nucleotide sequence of the longest UCS, identified in cDNA clone 3, extended 16 bp upstream of the sequence reported for rat P. carinii UCS 26 and formed a continuous ORF of 464 bp before diverging into the variable region of the gpA structural gene. Primer extension analysis of mouse P. carinii -infected lung RNA was performed to determine whether cDNA clone 3 included the entire UCS. Primer extensions of mouse P. carinii total RNA (Fig. 3) were performed using two distinct UCS-region antisense primers (UCS AS2 and AS3, lying 62 and 30 bp away from the 5' end of cDNA clone 3, respectively). mouse P. carinii UCS transcript is predicted to be approximately 490-495 nt. While a re-screening of the pool of nucleic acid-selected gpA cDNA clones with a 5' UCS probe identified ten additional clones, none contained sequence upstream of clone 3.
The genes encoding gpA are present in numerous copies dispersed across all chromosomes of P. ' 30 Among the isoforms of gpA genes and cDNAs isolated from the same host species, differences of ~10%-30% are typically observed at the levels of nucleotide or amino acid sequence, 29 indicating that gpA is likely a family of related genes. Even more striking than the intraspecies polymorphism of gpA isoform genes is the heterogeneity observed when this molecule is compared across distinct host species. Here, differences at the nucleotide and amino acid sequence lev-[Vol. 5, els become more prominent, reaching as high as 70% nonidentity.
3 ' 4 ' 6 ' 30 The genetic relatedness of different gpAs appears to correspond to the phylogenetic relatedness of the host species from which they are isolated, 4 ' 6 ' 30 ' 32 as demonstrated in the comparison of composite nucleotide and deduced amino acid sequences from rat 6 and mouse P. carinii gpA (Fig. 1) , which are approximately 70% similar. Cloning of the cDNA of a number of gpA isoforms has indicated that, at least within a population of P. carinii isolated from a single host species, these genes are transcribed into multiple distinct mRNAs. 3 
Furthermore, multiple gpA isoforms have been identified on P. carinii organisms isolated from a single animal using monoclonal antibodies. 33 The discovery of the UCS, that in rat-derived P. carinii is present in only one copy per genome 26 " 28 but is found at the 5' end of nearly all gpA isoform mRNAs, suggests that expression of gpA isoforms is regulated in some fashion. Yet, it is unknown whether a given organism is capable of expressing multiple distinct gpA isoforms at once, or whether regulatory mechanisms are in place such that one organism is able to express only one isoform at a time, with multiple organisms in a lung collectively expressing multiple distinct gpA isoforms. 33 In addition, can a given P. carinii organism change the gpA isoform expressed on its surface; and, if so, what is the mechanism of this antigenic switching or variation? Two possible scenarios, not necessarily mutually exclusive, could account for regulation of gpA isoform expression. In one, only those gpA isoforms immediately downstream of the UCS locus are transcribed, and various gpA isoform genes are translocated (singly and/or in arrays) to this locus via DNA recombination. The isoform diversity seen in the gpA genes located immediately downstream of the singlecopy UCS 26 ' 27 would support this scenario. This model is further supported by the observation that a tandem organization of a UCS and a gpA isoform gene occupies a telomeric location in the P. carinii genome, 28 ' 34 ' 35 which would facilitate reciprocal DNA recombination. In a second scenario, the UCS could be installed at the 5' end of distinct gpA transcripts via cis-splicing, irons-splicing, or both, of pre-mRNAs.
Recent studies on rat P. carinii demonstrate that the initiation of translation begins in the UCS to produce a pre-MSG protein. The translated portion of the UCS appears to serve as a leader peptide that is ultimately removed in the mature MSG molecule. 36 There are several potential start sites of translation in both the mouse and rat P. carinii UCS, as well as sequences upstream of the known UCS in both rat-and mouse-derived forms that remain uncharacterized. Hence, the actual start site of translation remains undetermined. Although the nucleotide sequence shown in Fig. 1 contains a continuous ORF, it is possible that translation may begin either upstream of the sequence shown, or at the methionine at residue 18.
Comparison of deduced amino acid sequences of
P. carinii gpA homologs derived from different host species. The deduced amino acid sequence of mouse P. carinii gpA was compared with homologs derived from rat, 6 human 30 and ferret 3 hosts. The overall similarity of mouse P. carinii gpA deduced amino acid sequences (Fig. 1) to rat-, human-and ferret-derived homologs was 71%, 58% and 54%, respectively. More striking, however, was the number of conserved amino acid residues, particularly cysteines, in homologs derived from all four hosts. Alignment of the four deduced amino acid sequences demonstrated 156 identical residues, including 46 cysteines (Fig. 4A) . In mouse P. carinii gpA, these residues were contained in several distinct domains (Fig. 4B ) beginning with the UCS followed by two highly conserved cysteine domains, and a proline-glycine rich region. A notable feature of the comparison is that the extensive proline-glycine domain seen in mouse P. carinii gpA (Fig. 1 , residues 957-1058) is completely absent in the human P. carinii homolog; the rat P. carinii homolog possesses a truncated version of this domain. 6 - 23 The proline-glycine domain may provide a region of constraint in the secondary structure of the gpA molecule in the mouse and rat homologs that would not be present in the human and ferret homologs. However, all four homologs share a short proline-rich region between cysteine domains I and n, 3 ' 6 ' 30 including two conserved proline residues (Fig. 4A, amino acids 401 and 407 ). This region may provide some constraint in secondary structure between the cysteine I and cysteine II domains of all the homologs.
Each of the four homologs ends with a short cysteinerich domain (cys III) and a serine-threonine domain. A region characteristic of a glycosyl phosphotidylinositol (GPI) protein anchor signal sequence is present at the carboxy terminus of all four homologs as well (Fig. 1, amino Using a mammalian cell model system, we have demonstrated that the ferret P. carinii gpA carboxy terminus can function as a GPI protein anchor signal sequence 3 * 37 (G. Guadiz et al., manuscript submitted). This feature would afford P. carinii a means by which to display gpA on its surface, and as a convenient mechanism by which to release gpA molecules from the cell surface that could be replaced by a new antigenic isoform of gpA. In this manner, analogous to the switching of the variant surface glycoprotein in Trypanosoma brucei, 38 P. carinii could alter its antigenic mosaic in order to evade immune recognition.
The marked conservation of cysteines and adjacent residues throughout the molecules from mouse, rat, human and ferret homologs (Fig. 4A) , as well as the conserved carboxy portion in all four homologs, suggests a common structure and function for gpA of all P. carinii. 4 Although cross-species conserved regions ex-References ist in the structural gpA gene, the paradigm of host species-specificity of gpA appears to govern the immunoreactivity of the molecule. With few exceptions, monoclonal antibodies raised against whole P. carinii or against native gpA react solely with P. carinii or gpA derived from the same host species as that of the original immunogen. 21 Finally, although it is unclear whether this observation is related to the host species-dependent uniqueness of gpA and/or of P. carinii per se, the transmissibility of P. carinii also appears to be restricted to hosts of the same species. 39 ' 40 Thus, the rational design of immunization schemes against P. carinii may be limited to the use of a P. carinii antigen that is derived from the same host species as that of the vaccine recipient, unless conserved regions common to shared antigens are targeted. With the molecular characterization of the mouse P. carinii UCS-gpA cDNA, we can begin to address these and other issues experimentally.
